Nexalin Technology Statistics

NASDAQ: NXLHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

3.63-0.48 (-11.68%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

After hours: 3.75 +3.31%

Nexalin Technology by the numbers

Nexalin Technology has a market capitalization of $3.0 million based on 829.40K shares outstanding. With trailing EPS of $-14.10, Nexalin Technology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 49.7% below its 50-day average and 70.6% below its 200-day average.

Average daily trading volume is 1.02M shares, or about $3.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NXL valuation vs. peer median

NXL compared with the median of 8 peer companies
Metric	NXL	Peer median	Difference
Market cap	$3.01M	$22.69M	-87%
Avg. volume	1.02M	105.31K	+869%

Peer median across 8 companies: VBIO, NUWE, NDRA, IRIX, ITOC, QTI, POCI, OM.

Valuation

Market cap: $3.01M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-14.10
Shares outstanding: 829.40K

Price and trading

Previous close: 4.11
Open: 3.95
Day range: 3.50 – 3.95
52-week range: 3.50 – 50.70
50-day moving average: 7.21
200-day moving average: 12.34
Beta: —
Volume: 67.28K
Average volume: 1.02M

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: —

Additional statistics

Market Cap: 3.01M
Forward Pe: -0.48
Eps: -14.10
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 50.70
Week52 Low: 3.50
Avg Volume: 1.02M
Shares Outstanding: 829.40K
Ma50: 7.21
Ma200: 12.34
Pct From52w High: -92.84%
Pct From52w Low: 3.71%